(Q54358496)

English

Neuroendocrine cancer. An activating hotspot mutation in PRKACA provides clues for adrenal Cushing syndrome therapeutics.

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24751881

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24751881

title

Neuroendocrine cancer. An activating hotspot mutation in PRKACA provides clues for adrenal Cushing syndrome therapeutics. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24751881

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24751881

author name string

Jennifer Sargent

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24751881

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24751881

publication date

22 April 2014

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24751881

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24751881

published in

Nature Reviews Endocrinology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24751881

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24751881

volume

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24751881

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24751881

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24751881

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24751881

page(s)

311

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24751881

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24751881

cites work

Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24751881

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NRENDO.2014.57

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24751881

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24751881

PubMed publication ID

24751881

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24751881

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24751881

(Q54358496)

Neuroendocrine cancer. An activating hotspot mutation in PRKACA provides clues for adrenal Cushing syndrome therapeutics.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)